BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36098652)

  • 1. The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.
    Hao D; Han G; Sinjab A; Gomez-Bolanos LI; Lazcano R; Serrano A; Hernandez SD; Dai E; Cao X; Hu J; Dang M; Wang R; Chu Y; Song X; Zhang J; Parra ER; Wargo JA; Swisher SG; Cascone T; Sepesi B; Futreal AP; Li M; Dubinett SM; Fujimoto J; Solis Soto LM; Wistuba II; Stevenson CS; Spira A; Shalapour S; Kadara H; Wang L
    Cancer Discov; 2022 Nov; 12(11):2626-2645. PubMed ID: 36098652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes.
    Isaeva OI; Sharonov GV; Serebrovskaya EO; Turchaninova MA; Zaretsky AR; Shugay M; Chudakov DM
    J Immunother Cancer; 2019 Oct; 7(1):279. PubMed ID: 31665076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
    Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
    Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing.
    Sinjab A; Han G; Treekitkarnmongkol W; Hara K; Brennan PM; Dang M; Hao D; Wang R; Dai E; Dejima H; Zhang J; Bogatenkova E; Sanchez-Espiridion B; Chang K; Little DR; Bazzi S; Tran LM; Krysan K; Behrens C; Duose DY; Parra ER; Raso MG; Solis LM; Fukuoka J; Zhang J; Sepesi B; Cascone T; Byers LA; Gibbons DL; Chen J; Moghaddam SJ; Ostrin EJ; Rosen D; Heymach JV; Scheet P; Dubinett SM; Fujimoto J; Wistuba II; Stevenson CS; Spira A; Wang L; Kadara H
    Cancer Discov; 2021 Oct; 11(10):2506-2523. PubMed ID: 33972311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
    Fujimoto J; Nunomura-Nakamura S; Liu Y; Lang W; McDowell T; Jakubek Y; Ezzeddine D; Kapere Ochieng J; Petersen J; Davies G; Fukuoka J; Wistuba II; Ehli E; Fowler J; Scheet P; Kadara H
    Int J Cancer; 2017 Oct; 141(8):1589-1599. PubMed ID: 28653505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.
    Devarakonda S; Li Y; Martins Rodrigues F; Sankararaman S; Kadara H; Goparaju C; Lanc I; Pepin K; Waqar SN; Morgensztern D; Ward J; Masood A; Fulton R; Fulton L; Gillette MA; Satpathy S; Carr SA; Wistuba I; Pass H; Wilson RK; Ding L; Govindan R
    J Clin Oncol; 2021 Nov; 39(33):3747-3758. PubMed ID: 34591593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
    Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
    J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparate genomic characteristics of patients with early-stage lung adenocarcinoma manifesting as radiological subsolid or solid lesions.
    Li H; Sun Z; Li Y; Qi Q; Huang H; Wang X; Zhou J; Liu K; Yin P; Wang Z; Li X; Yang F
    Lung Cancer; 2022 Apr; 166():178-188. PubMed ID: 35303645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung adenocarcinoma manifesting as subsolid nodule potentially represents tumour in the equilibrium phase of immunoediting.
    Xiao R; Ma Y; Li H; Li X; Sun Z; Qi Q; Yin P; Yang F; Qiu M
    Immunology; 2023 Feb; 168(2):290-301. PubMed ID: 35503794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma.
    Li D; Yu H; Hu J; Li S; Yan Y; Li S; Sun L; Jiang G; Hou L; Zhang L; Zhang P
    J Transl Med; 2022 Sep; 20(1):423. PubMed ID: 36138435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers.
    Luo W; Zeng Z; Jin Y; Yang L; Fan T; Wang Z; Pan Y; Yang Y; Yao M; Li Y; Xiao X; Wang G; Wang C; Chang S; Che G; Zhang L; Li Y; Peng Y; Li W
    Cell Rep Med; 2023 Jun; 4(6):101078. PubMed ID: 37301197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
    Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
    Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
    Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
    Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
    [No Abstract]   [Full Text] [Related]  

  • 15. Deep exploration of immune function in EGFR wild-type and mutated lung adenocarcinomas by gene expression profiling: role of TRAIL-R2 (TNFRSF10B) in patient treatment and outcome.
    Chang WC; Yeh YC; Ho HL; Chou TY
    Hum Pathol; 2022 Aug; 126():9-18. PubMed ID: 35550831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic landscape of lung adenocarcinoma in East Asians.
    Chen J; Yang H; Teo ASM; Amer LB; Sherbaf FG; Tan CQ; Alvarez JJS; Lu B; Lim JQ; Takano A; Nahar R; Lee YY; Phua CZJ; Chua KP; Suteja L; Chen PJ; Chang MM; Koh TPT; Ong BH; Anantham D; Hsu AAL; Gogna A; Too CW; Aung ZW; Lee YF; Wang L; Lim TKH; Wilm A; Choi PS; Ng PY; Toh CK; Lim WT; Ma S; Lim B; Liu J; Tam WL; Skanderup AJ; Yeong JPS; Tan EH; Creasy CL; Tan DSW; Hillmer AM; Zhai W
    Nat Genet; 2020 Feb; 52(2):177-186. PubMed ID: 32015526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma.
    Behrens C; Rocha P; Parra ER; Feng L; Rodriguez-Canales J; Solis LM; Mino B; Zhang J; Gibbons DL; Sepesi B; Rice D; Heymach JV; Moran C; Creighton CJ; Lee JJ; Kadara H; Wistuba II
    Clin Lung Cancer; 2021 May; 22(3):e415-e424. PubMed ID: 32763065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-biased molecular differences in lung adenocarcinoma are ethnic and smoking specific.
    Li X; Wei S; Deng L; Tao H; Liu M; Zhao Z; Du X; Li Y; Hou J
    BMC Pulm Med; 2023 Mar; 23(1):99. PubMed ID: 36964522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in Single-cell RNA Sequencing of Lung Adenocarcinoma].
    Lin Y; Chen D; Ding Q; Zhu X; Zhu R; Chen Y
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):434-440. PubMed ID: 34024063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a ZC3H12D-regulated competing endogenous RNA network for prognosis of lung adenocarcinoma at single-cell level.
    Chen W; Guo Z; Wu J; Lin G; Chen S; Lin Q; Yang J; Xu Y; Zeng Y
    BMC Cancer; 2022 Jan; 22(1):115. PubMed ID: 35090416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.